Back
Vertex Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
44
VRTX
Vertex Pharmaceuticals
Last Price:
$438.72
Seasonality Move:
7.54%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 431.87 | Buy |
| 20-day SMA: | 468.07 | Sell |
| 50-day SMA: | 483.34 | Sell |
| 200-day SMA: | 468.95 | Sell |
| 8-day EMA: | 440.09 | Sell |
| 20-day EMA: | 458.27 | Sell |
| 50-day EMA: | 471 | Sell |
| 200-day EMA: | 463.03 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -15.93 | Sell |
| Relative Strength Index (14 RSI): | 39.02 | Sell |
| Chaikin Money Flow: | 1405076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (442.55 - 502.81) | Sell |
| Bollinger Bands (100): | (428.12 - 497.94) | Sell |
Vertex Pharmaceuticals Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 438.65 while VRTX 8-day simple moving average is 431.87, which is a Buy signal.
-
The stock price of VRTX is 438.65 while Vertex Pharmaceuticals 20-day SMA is 468.07, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day simple moving average is 483.34 while VRTX share price is 438.65, making it a Sell technically.
-
VRTX stock price is 438.65 and Vertex Pharmaceuticals 200-day simple moving average is 468.95, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
44
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $438.65. The Score for VRTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
112.6B
Price in USD:
438.65
Share Volume:
1.5M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
44
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 438.65 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 438.65 while VRTX 8-day exponential moving average is 440.09, which is a Sell signal.
-
The stock price of VRTX is 438.65 while Vertex Pharmaceuticals 20-day EMA is 458.27, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day exponential moving average is 471.00 while VRTX share price is 438.65, making it a Sell technically.
-
VRTX stock price is 438.65 and Vertex Pharmaceuticals 200-day simple moving average is 463.03, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.39 per share, an increase this year of $17.52 per share, and an increase next year of $2.66 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is -15.93, suggesting Vertex Pharmaceuticals is a Sell
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 39.02, which suggest Vertex Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (442.55 - 502.81), which suggest Vertex Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (428.12 - 497.94), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.